This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1989 Sep;14(3):163-9.

doi: 10.1016/s0272-6386(89)80066-6.

Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation

No authors listed

PMID: 2672796
DOI: 10.1016/s0272-6386(89)80066-6

Review

Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation

No authors listed. Am J Kidney Dis. 1989 Sep.

. 1989 Sep;14(3):163-9.

doi: 10.1016/s0272-6386(89)80066-6.

PMID: 2672796
DOI: 10.1016/s0272-6386(89)80066-6

No abstract available

PubMed Disclaimer

Similar articles

[Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
Jalil R, Vaccarezza A, Jara A, Lira P, Vial S, Serrano V. Jalil R, et al. Rev Med Chil. 1990 Jun;118(6):629-34. Rev Med Chil. 1990. PMID: 1775783 Spanish.
Erythropoietin and peritoneal dialysis: the efficacy of intraperitoneal dosing.
Nissenson AR. Nissenson AR. Perit Dial Int. 1992;12(4):350-2. Perit Dial Int. 1992. PMID: 1420491 No abstract available.
Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
Korbet SM. Korbet SM. Kidney Int Suppl. 1993 Feb;40:S111-9. Kidney Int Suppl. 1993. PMID: 8445832 Review. No abstract available.
Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration.
Eisele G, Bailie GR, Clement C, Wong E. Eisele G, et al. Perit Dial Int. 1992;12(1):34-6. Perit Dial Int. 1992. PMID: 1543777
Erythropoietin use in peritoneal dialysis patients.
Zimmerman SW, Johnson CA. Zimmerman SW, et al. Am J Kidney Dis. 1991 Oct;18(4 Suppl 1):38-41. Am J Kidney Dis. 1991. PMID: 1928078 Review.

See all similar articles

Cited by

A review of the first year of Medicare coverage of erythropoietin.
Griffiths RI, Powe NR, Greer J, de Lissovoy G, Anderson GF, Whelton PK, Watson AJ, Eggers PW. Griffiths RI, et al. Health Care Financ Rev. 1994 Spring;15(3):83-102. Health Care Financ Rev. 1994. PMID: 10137799 Free PMC article.
Controversies in determination of epoetin (recombinant human erythropoietin) dosages.
Abraham PA, St Peter WL, Redic-Kill KA, Halstenson CE. Abraham PA, et al. Clin Pharmacokinet. 1992 Jun;22(6):409-15. doi: 10.2165/00003088-199222060-00001. Clin Pharmacokinet. 1992. PMID: 1587054 Review. No abstract available.
Change in haemoglobin concentration, haematocrit and vasoactive hormones in haemodialysis patients with erythropoietin-associated hypertension.
Sasagawa I, Nakada T, Hashimoto T, Kubota Y, Suzuki H, Sawamura T. Sasagawa I, et al. Int Urol Nephrol. 1994;26(2):237-43. doi: 10.1007/BF02768293. Int Urol Nephrol. 1994. PMID: 8034437

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information